The new treatment options for diabetic and non-diabetic kidney disease

Nowadays, more than 850 million people worldwide suffer from kidney disease. Over the last ten years, new therapeutic options have been discovered for slowing down chronic kidney disease progression.
In this book, new multidisciplinary strategies (e.g., related to nephrology, cardiology, primary care, endocrinology, etc.) for treating patients suffering from chronic kidney disease - with and without diabetes - are fully explained and detailed.
This book will give the reader the opportunity to delve into the risk factors for chronic kidney disease progression and its multifactorial treatment, to analyze the classical renin-angiotensin system protection, and to examine in depth the new strategies already present on the market for delaying kidney disease progression and decreasing cardiovascular risk in patients at high risk of cardiovascular mortality.
Even though in the last decade the future of people with chronic kidney has clearly improved, the implementation of already accepted renoprotective strategies and new therapies is still crucial to prevent kidney disease from progressing to its end stage.